BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3209678)

  • 1. Corticosteroid-induced cleft palate in short-ear mice.
    Marazita ML; Jaskoll T; Melnick M
    J Craniofac Genet Dev Biol; 1988; 8(1):47-51. PubMed ID: 3209678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diazepam-induced cleft palate in the mouse and lack of correlation with the H-2 locus.
    Tocco DR; Renskers K; Zimmerman EF
    Teratology; 1987 Jun; 35(3):439-45. PubMed ID: 3629520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation of the role of N-acetyltransferase 2 in teratogen-induced cleft palate using transgenics and knockouts.
    Erickson RP; Cao W; Acuña DK; Strnatka DW; Hunter RJ; Chau BT; Wakefield LV; Sim E; McQueen CA
    Mol Reprod Dev; 2008 Jun; 75(6):1071-6. PubMed ID: 18161794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relations of palatal slit, cleft palate, and fetal mortality in mice treated with a glucocorticoid.
    Kusanagi T
    Teratology; 1983 Oct; 28(2):165-8. PubMed ID: 6648820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glucocorticoid receptor in fetal mouse: its relationship to cleft palate formation.
    Hackney JF
    Teratology; 1980 Feb; 21(1):39-51. PubMed ID: 7385055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in extracellular matrix components and cell density during normal and dexamethasone-treated secondary palate development in two strains of mice with different susceptibility to glucocorticoid induced-clefting.
    Montenegro MA; Rojas M; Dominguez S; Rosales CJ
    J Craniofac Genet Dev Biol; 1998; 18(2):100-6. PubMed ID: 9672842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CORT-GR signal transduction pathway and CORT-induced cleft palate in H-2 congenic mice.
    Jaskoll T; Choy HA; Chen H; Melnick M
    J Craniofac Genet Dev Biol; 1995; 15(2):57-65. PubMed ID: 7635930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of triamcinolone-induced cleft palate in mice by maternal high dietary fat.
    Zhou M; Walker BE
    Teratology; 1993 Jul; 48(1):53-7. PubMed ID: 8351648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and metabolism of triamcinolone acetonide in inbred mice with different cleft palate sensitivities.
    Zimmerman EF; Bowen D
    Teratology; 1972 Jun; 5(3):335-43. PubMed ID: 5032642
    [No Abstract]   [Full Text] [Related]  

  • 10. Strain differences between C57BL/6 and SWV mice in time of palate closure and induction of palatal slit and cleft palate.
    Kusanagi T
    Teratology; 1985 Apr; 31(2):279-83. PubMed ID: 3992497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teratogenicity of triamcinolone acetonide in rats.
    Rowland JM; Hendrickx AG
    Teratology; 1983 Feb; 27(1):13-8. PubMed ID: 6845214
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitive stages and dose-response analyses of palatal slit and cleft palate in C57BL/6 mice treated with a glucocorticoid.
    Kusanagi T
    Teratology; 1984 Apr; 29(2):281-6. PubMed ID: 6740512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinants in the H-2S/H-2D interval of mouse chromosome 17 define the map position of a gene for cleft palate susceptibility.
    Gasser DL; Yadvish KN; Trammell MA; Goldman AS
    Teratology; 1988 Dec; 38(6):571-7. PubMed ID: 3238613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid-induced cleft lip in mice: a teratologic, topographic, and histologic investigation.
    Melnick M; Jaskoll T; Slavkin HC
    Am J Med Genet; 1981; 10(4):333-50. PubMed ID: 7332028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of cleft palate, palatal slit, and fetal death in mice treated with a glucocorticoid: an embryo transfer experiment.
    Kusanagi T
    Teratology; 1983 Jun; 27(3):395-400. PubMed ID: 6879461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H-2 haplotype and heterochronic orofacial morphogenesis in congenic mice: consideration as a possible explanation for differential susceptibility to teratogenesis.
    Melnick M; Jaskoll T
    J Craniofac Genet Dev Biol; 1992; 12(4):190-5. PubMed ID: 1494024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid-induced mandibular growth retardation and palatal malformation in the ICR mouse fetus.
    Silbermann M; Levitan S
    J Anat; 1979 Jun; 128(Pt 4):747-65. PubMed ID: 489465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palatal width growth rates as the genetic determinant of cleft palate induced by vitamin A.
    Siegel MI; Mooney MP
    J Craniofac Genet Dev Biol Suppl; 1986; 2():187-91. PubMed ID: 3491112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of dose-response relationships to discriminate between the mechanisms of cleft-palate induction by different teratogens: an argument for discussion.
    Biddle FG
    Teratology; 1978 Oct; 18(2):247-52. PubMed ID: 715728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility complex (H-2)-linked genes affecting teratogen-induced congenital craniofacial malformations in mice.
    Slavkin HC
    Prog Clin Biol Res; 1980; 46():121-47. PubMed ID: 7267650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.